↓ Skip to main content

Adjuvant Therapy for Breast Cancer

Overview of attention for book
Cover of 'Adjuvant Therapy for Breast Cancer'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 History of Adjuvant Therapy
  3. Altmetric Badge
    Chapter 2 Prognostic and Predictive Factors
  4. Altmetric Badge
    Chapter 3 New Perspectives for Therapy Choice
  5. Altmetric Badge
    Chapter 4 Pathology Role in Adjuvant Setting
  6. Altmetric Badge
    Chapter 5 Guidelines, Consensus Conferences and Overviews (Meta-analysis)
  7. Altmetric Badge
    Chapter 6 Statistical Issues and Challenges
  8. Altmetric Badge
    Chapter 7 Adjuvant Therapy for Breast Cancer
  9. Altmetric Badge
    Chapter 8 Preoperative Chemo- and Endocrine Therapy
  10. Altmetric Badge
    Chapter 9 Adjuvant Chemotherapy
  11. Altmetric Badge
    Chapter 10 Postoperative endocrine therapy for invasive breast cancer.
  12. Altmetric Badge
    Chapter 11 Adjuvant Therapy of Breast Cancer – Bisphosphonates
  13. Altmetric Badge
    Chapter 12 Trastuzumab
  14. Altmetric Badge
    Chapter 13 Lapatinib: new directions in HER2 directed therapy for early stage breast cancer.
  15. Altmetric Badge
    Chapter 14 Supportive Care During Adjuvant Treatment
  16. Altmetric Badge
    Chapter 15 Dose in (Adjuvant) Chemotherapy of Breast Cancer
  17. Altmetric Badge
    Chapter 16 Timing of Adjuvant Therapy
  18. Altmetric Badge
    Chapter 17 Sequencing of Systemic Treatment and Radiotherapy
  19. Altmetric Badge
    Chapter 18 Young Patients with Breast Cancer
  20. Altmetric Badge
    Chapter 19 Special Populations: Elderly Patients
  21. Altmetric Badge
    Chapter 20 Adjuvant Therapy in Patients with Breast Cancer During Pregnancy
  22. Altmetric Badge
    Chapter 21 Investigations After Adjuvant Therapy
  23. Altmetric Badge
    Chapter 22 Quality of Life Issues During Adjuvant Endocrine Therapy
  24. Altmetric Badge
    Chapter 23 Fertility
  25. Altmetric Badge
    Chapter 24 Cognitive Function in Breast Cancer Survivors
  26. Altmetric Badge
    Chapter 25 Costs of Adjuvant Breast Cancer Treatments
  27. Altmetric Badge
    Chapter 26 Social Issues: Marital Support
  28. Altmetric Badge
    Chapter 27 The View and Role of Breast Cancer Advocacy
  29. Altmetric Badge
    Chapter 28 The Voice of a Special Patient
Attention for Chapter 13: Lapatinib: new directions in HER2 directed therapy for early stage breast cancer.
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Lapatinib: new directions in HER2 directed therapy for early stage breast cancer.
Chapter number 13
Book title
Adjuvant Therapy for Breast Cancer
Published in
Cancer treatment and research, December 2008
DOI 10.1007/978-0-387-75115-3_13
Pubmed ID
Book ISBNs
978-0-387-75114-6, 978-0-387-75115-3
Authors

Jo Chien A, Rugo HS, A. Jo Chien, Hope S. Rugo

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 2 33%
Librarian 1 17%
Unspecified 1 17%
Researcher 1 17%
Student > Bachelor 1 17%
Other 0 0%
Readers by discipline Count As %
Medicine and Dentistry 2 33%
Unspecified 1 17%
Economics, Econometrics and Finance 1 17%
Agricultural and Biological Sciences 1 17%
Unknown 1 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2012.
All research outputs
#18,313,878
of 22,675,759 outputs
Outputs from Cancer treatment and research
#122
of 164 outputs
Outputs of similar age
#156,925
of 168,314 outputs
Outputs of similar age from Cancer treatment and research
#8
of 12 outputs
Altmetric has tracked 22,675,759 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 164 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,314 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.